Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    18385500 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Condition: Atopic Dermatitis
Intervention:
2 Completed Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Cis-UCA 2.5% emulsion cream;   Drug: Cis-UCA 5% emulsion cream;   Drug: Placebo for cis-UCA emulsion cream;   Drug: Protopic® 0.1% ointment
3 Recruiting A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
Condition: Dermatitis, Atopic
Intervention: Drug: Triamcinolone 0.1%

Indicates status has not been verified in more than two years